Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older Patients.
Mao-Draayer Y, Bar-Or A, Balashov K, Foley J, Smoot K, Longbrake EE, Robertson D, Mendoza JP, Lewin JB, Everage N, Božin I, Lyons J, Mokliatchouk O, Bame E, Giuliani F. Mao-Draayer Y, et al. Among authors: bozin i. Adv Ther. 2024 Nov 21. doi: 10.1007/s12325-024-03047-w. Online ahead of print. Adv Ther. 2024. PMID: 39570545
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants: Real-world evidence from MSBase.
Spelman T, Eichau S, Alroughani R, Ozakbas S, Khoury SJ, Patti F, Kubala Havrdova E, Boz C, Terzi M, Kuhle J, Grammond P, Lechner-Scott J, Gray O, Amato MP, Laureys G, Shaygannejad V, Hyde R, Wang H, Bozin I, Belviso N, Quan C, Zeng F, van der Walt A, Butzkueven H; MSBase Study Group. Spelman T, et al. Among authors: bozin i. Mult Scler J Exp Transl Clin. 2024 May 25;10(2):20552173241247182. doi: 10.1177/20552173241247182. eCollection 2024 Apr-Jun. Mult Scler J Exp Transl Clin. 2024. PMID: 38800132 Free PMC article.
Response to Letter to the Editor Regarding "Real-World Analysis Affirms the High Persistence and Adherence Observed with Diroximel Fumarate in Patients with Multiple Sclerosis".
Lager B, Liseno J, Božin I, England SM, Shankar SL, Mendoza JP, Lewin JB. Lager B, et al. Among authors: bozin i. Neurol Ther. 2023 Dec;12(6):2199-2203. doi: 10.1007/s40120-023-00536-y. Epub 2023 Sep 14. Neurol Ther. 2023. PMID: 37707704 Free PMC article. No abstract available.
Vaccine response in people with multiple sclerosis treated with fumarates.
Tremblay MA, Vukusic S, Shanmugasundaram M, Bozin I, Levin S, Gocke A, Wipfler P. Tremblay MA, et al. Among authors: bozin i. Mult Scler J Exp Transl Clin. 2023 Sep 6;9(3):20552173231191170. doi: 10.1177/20552173231191170. eCollection 2023 Jul-Sep. Mult Scler J Exp Transl Clin. 2023. PMID: 37692293 Free PMC article. Review.
Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM.
Williams MJ, Amezcua L, Chinea A, Cohan S, Okai A, Okuda DT, Vargas W, Belviso N, Božin I, Jiang X, Lewin JB, Lyons J, Shen C, England SM, Grimes N. Williams MJ, et al. Among authors: bozin i. Neurol Ther. 2023 Oct;12(5):1669-1682. doi: 10.1007/s40120-023-00517-1. Epub 2023 Jun 24. Neurol Ther. 2023. PMID: 37354276 Free PMC article.
16 results